The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Open accessAbstract
The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in ~40% of genes, with the landscape dominated by cis- and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA–RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the ‘CNA-devoid’ subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Currently, numerous research efforts are focused on utilizing genetic data and artificial intelligence algorithms to develop diagnostic models to enhance the clinical efficiency and accuracy of breast cancer diagnosis [109,110,111].”
From A Comprehensive Review on Synergy of Multi-Modal Data and AI Technologies in Medical Diagnosis (2024) · cites this paper as [111]
In the citing paper
“This framework was also employed for a landmark study which used genomic and transcriptomic data from 2,000 breast tumours and discovered novel subgroups amongst them (Curtis et al., 2012).”
From Using machine learning approaches for multi-omics data analysis: A review (2021) · cites this paper as Curtis et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C., Sørlie, T., Eisen, M., van de Rijn, M., Jeffrey, S., Rees, C. A., Pollack, J., Ross, D., Johnsen, H., Akslen, L., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,551
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Self-citationSupervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S. C. Y., Voduc, D. K., Vickery, T. L., Davies, S. R., Fauron, C. M. ‐., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,818
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Ki67 expression in breast cancer
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Diagnosis of multiple cancer types by shrunken centroids of gene expression
Tibshirani, R. J., Hastie, T. J., Narasimhan, B., & Chu, G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082099299 · Cited by 2,931
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,411
Self-citationGenomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A. V., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,309
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
Jones, S., Wang, T., Shih, I., Mao, T., Nakayama, K., Roden, R. B. S., Glas, R., Slamon, D. J., Diaz, L. A., Vogelstein, B., et al. (2010) · Science · doi:10.1126/science.1196333 · Cited by 1,218
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,028
Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Kaliński, P., Endo, I., & Takabe, K. (2020) · Cancers · doi:10.3390/cancers12113342 · Cited by 97
Meeusen, B., & Janssens, V. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.002 · Cited by 96
Expression of androgen receptor splice variants in clinical breast cancers
Hickey, T. E., Irvine, C. M., Dvinge, H., Tarulli, G. A., Hanson, A. R., Ryan, N. K., Pickering, M. A., Birrell, S. N., Hu, D. G., Mackenzie, P. I., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6296 · Cited by 99
Self-citationLuo, L., McGarvey, P. B., Madhavan, S., Kumar, R., Gusev, Y., & Upadhyay, G. (2016) · Oncotarget · doi:10.18632/oncotarget.7163 · Cited by 99
Resistance to Intervention: Paclitaxel in Breast Cancer
Dan, V. M., Raveendran, R. S., & Baby, S. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520999201214234421 · Cited by 98
MaTAR25 lncRNA regulates the Tensin1 gene to impact breast cancer progression
Chang, K.-C., Diermeier, S. D., Yu, A. T., Brine, L., Russo, S., Bhatia, S., Alsudani, H., Kostroff, K. M., Bhuiya, T. A., Brogi, E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20207-y · Cited by 98
Yu, B., Luo, F., Sun, B., Liu, W., Shi, Q., Cheng, S., Chen, C., Chen, G., Li, Y., & Feng, H. (2021) · Advanced Science · doi:10.1002/advs.202100014 · Cited by 98
Multiomics technologies: role in disease biomarker discoveries and therapeutics
Dar, M. A., Arafah, A. M., Bhat, K. A., Khan, A., Khan, M. S., Ali, A., Ahmad, S. M., Rashid, S. M., & Rehman, M. U. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac017 · Cited by 102
Patel, H., Abduljabbar, R. F., Lai, C., Periyasamy, M., Harrod, A., Gemma, C., Steel, J. H., Patel, N. R., Busonero, C., Jerjees, D. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1104 · Cited by 99
Self-citationLi, B., Chonghaile, T. N., Fan, Y., Madden, S. F., Klinger, R. W., O’Connor, A. E., Walsh, L., O’Hurley, G., Udupi, G. M., Joseph, J., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2546 · Cited by 97
Self-citationmiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer
Mathe, A., Scott, R. J., & Avery‐Kiejda, K. A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226090 · Cited by 97
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
den Hollander, P., Rawls, K., Tsimelzon, A. I., Shepherd, J. H., Mazumdar, A., Hill, J. L., Fuqua, S. A. W., Chang, J. C., Osborne, C. K., Hilsenbeck, S. G., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-0673 · Cited by 97
Metabolic Footprints and Molecular Subtypes in Breast Cancer
Cappelletti, V., Iorio, E., Miodini, P., Silvestri, M., Dugo, M., & Daidone, M. G. (2017) · Disease Markers · doi:10.1155/2017/7687851 · Cited by 99
Molecular Portrait of Hypoxia in Breast Cancer: A Prognostic Signature and Novel HIF-Regulated Genes
Ye, I. C., Fertig, E. J., DiGiacomo, J. W., Considine, M., Godet, I., & Gilkes, D. M. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0345 · Cited by 96
CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets
Cortázar, A. R., Torrano, V., Martín-Martín, N., Caro‐Maldonado, A., Camacho, L., Heřmanová, I., Guruceaga, E., Lorenzo‐Martín, L. F., Caloto, R., Gomis, R. R., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1669 · Cited by 95
Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer
Sridharan, S., & Basu, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041199 · Cited by 95
Beltrán, A. S., Graves, L. M., & Blancafort, P. (2013) · Oncogene · doi:10.1038/onc.2013.422 · Cited by 95
Stolzenburg, S., Beltrán, A. S., Swift‐Scanlan, T., Rivenbark, A. G., Rashwan, R., & Blancafort, P. (2015) · Oncogene · doi:10.1038/onc.2014.470 · Cited by 94
A dried blood spot mass spectrometry metabolomic approach for rapid breast cancer detection
Cao, Y., Wang, Q., Gao, P., Dong, J., Zhu, Z., Fang, Y., Fang, Z., Sun, X., & Sun, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s95862 · Cited by 96
Genetic Alterations of TRAF Proteins in Human Cancers
Zhu, S., Jin, J., Gokhale, S., Lu, A. M., Shan, H., Feng, J., & Xie, P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02111 · Cited by 96
BRCA1 Deficiency Impairs Mitophagy and Promotes Inflammasome Activation and Mammary Tumor Metastasis
Chen, Q., Lei, J. H., Bao, J., Wang, H., Hao, W., Li, L., Peng, C., Masuda, T., Miao, K., Xu, J., et al. (2020) · Advanced Science · doi:10.1002/advs.201903616 · Cited by 96
Lappano, R., Talia, M., Cirillo, F., Rigiracciolo, D. C., Scordamaglia, D., Guzzi, R., Miglietta, A., Francesco, E. M. D., Belfiore, A., Sims, A. H., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01667-y · Cited by 97
Gan, S., Macalinao, D. G., Shahoei, S. H., Tian, L. H., Jin, X., Basnet, H., Bibby, C., Muller, J., Atri, P., Seffar, E., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.08.015 · Cited by 96
Chen, H., Deng, C., Gao, J., Wang, J., Fu, F., Wang, Q., Wang, Q., Zhang, S., Zhang, S., Fan, F., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.01.012 · Cited by 98
Liu, B., Morrison, C. D., Johnson, C. S., Trump, D. L., Qin, M., Conroy, J., Wang, J., & Liu, S. (2013) · Oncotarget · doi:10.18632/oncotarget.1537 · Cited by 96
Inference of transcriptional regulation in cancers
Jiang, P., Freedman, M. L., Liu, J. S., & Liu, X. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424272112 · Cited by 93
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network
Fasching, P. A., Brucker, S. Y., Fehm, T. N., Overkamp, F., Janni, W., Wallwiener, M., Hadji, P., Belleville, E., Häberle, L., Taran, F., et al. (2015) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0034-1396215 · Cited by 93
Breast Cancer Genomics From Microarrays to Massively Parallel Sequencing: Paradigms and New Insights
Ng, C. K. Y., Schultheis, A. M., Bidard, F., Weigelt, B., & Reis-Filho, J. S. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv015 · Cited by 96
Fredlund, E., Staaf, J., Rantala, J., Kallioniemi, O., Borg, Å., & Ringnér, M. (2012) · Breast Cancer Research · doi:10.1186/bcr3236 · Cited by 93
Autocrine Fibronectin Inhibits Breast Cancer Metastasis
Shinde, A. B., Libring, S., Alpsoy, A., Abdullah, A., Schaber, J. A., Solorio, L., & Wendt, M. K. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0151 · Cited by 93
Estrogen receptor signaling is reprogrammed during breast tumorigenesis
Chi, D., Singhal, H., Li, L., Xiao, T., Liu, W., Pun, M. J., Jeselsohn, R. M., He, H., Lim, E., Vadhi, R., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819155116 · Cited by 94
Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis
Wang, R., Godet, I., Yang, Y., Salman, S., Lu, H., Lyu, Y., Zuo, Q., Wang, Y., Zhu, Y., Chen, C. O., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020490118 · Cited by 93
Kottakis, F., Foltopoulou, P. F., Sanidas, I., Keller, P. J., Wronski, A., Dake, B. T., Ezell, S. A., Shen, Z., Naber, S. P., Hinds, P. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2733 · Cited by 95
Integration of Genomic Data Enables Selective Discovery of Breast Cancer Drivers
Sanchez-Garcia, F., Villagrasa, P., Matsui, J., Kotliar, D., Castro, V., Akavia, U.-D., Chen, B.-J., Saucedo-Cuevas, L. P., Barrueco, R. R., Llobet‐Navàs, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.10.048 · Cited by 92
Ku, C., & Roukos, D. H. (2013) · Expert Review of Medical Devices · doi:10.1586/erd.12.63 · Cited by 95
Principal Graph and Structure Learning Based on Reversed Graph Embedding
Mao, Q., Wang, L., Tsang, I. W.-H., & Sun, Y. (2016) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/tpami.2016.2635657 · Cited by 92
Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer
Dreijerink, K. M. A., Groner, A. C., Vos, E. S. M., Font‐Tello, A., Gu, L., Chi, D., Reyes, J. M., Cook, J., Lim, E., Lin, C. Y., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.025 · Cited by 96
The GRHL2/ZEB Feedback Loop-A Key Axis in the Regulation of EMT in Breast Cancer
Mooney, S. M., Talebian, V., Jolly, M. K., Jia, D., Gromala, M., Levine, H., & McConkey, B. J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25974 · Cited by 92
MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer
Craze, M. L., Cheung, H., Jewa, N., Coimbra, N. D. M., Soria, D., Ansari, R. E., Aleskandarany, M. A., Cheng, K. W., Diez, M., Nolan, C. C., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.387 · Cited by 92
Self-citationWerfel, T. A., Elion, D. L., Rahman, B., Hicks, D. J., Sanchez, V. M., Ericsson, P. I. G., Nixon, M. J., James, J. L., Balko, J. M., Scherle, P., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1106 · Cited by 94
SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
Fenizia, C., Bottino, C., Corbetta, S., Fittipaldi, R., Floris, P., Gaudenzi, G., Carra, S., Cotelli, F., Vitale, G., & Caretti, G. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1221 · Cited by 92
Pathway‐level mutational signatures predict breast cancer outcomes and reveal therapeutic targets
Posta, M., & Győrffy, B. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70215 · Cited by 109
Ali, H. R., Dariush, A., Provenzano, E., Bardwell, H. A., Abraham, J., Iddawela, M. Y., Vallier, A.-L., Hiller, L., Dunn, J., Bowden, S. J., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0682-8 · Cited by 93
Self-citationPembrolizumab for Early Triple-Negative Breast Cancer
Schmid, P., Dent, R., & O’Shaughnessy, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2006684 · Cited by 92
Teleki, I., Szász, A. M., Maros, M. E., Győrffy, B., Kulka, J., Meggyesházi, N., Kiszner, G., Balla, P., Aliz, S., & Krenács, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112541 · Cited by 91
Cheng, Y., Xiang, G., Meng, Y.-B., & Dong, R. (2016) · Reproductive Biology · doi:10.1016/j.repbio.2016.07.002 · Cited by 93
Wang, J., Wang, B., Ren, H., & Chen, W. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.12.114 · Cited by 91
A deep survival analysis method based on ranking
Jing, B., Zhang, T., Wang, Z., Jin, Y., Liu, K., Qiu, W., Ke, L., Sun, Y. H., He, C., Hou, D., et al. (2019) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2019.06.001 · Cited by 91
Zheng, S., Zou, Y., Tang, Y., Yang, A., Liang, J.-Y., Wu, L., Tian, W., Xiao, W., Xie, X., Yang, L., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2020984 · Cited by 92
Baenke, F., Dubuis, S., Brault, C., Weigelt, B., Dankworth, B., Griffiths, B. L., Jiang, M., Mackay, A. G., Saunders, B., Spencer‐Dene, B., et al. (2015) · The Journal of Pathology · doi:10.1002/path.4562 · Cited by 93
Verhaegh, W., van Ooijen, H., de Inda, M. A., Hatzis, P., Versteeg, R., Smid, M., Martens, J. W. M., Foekens, J. A., van de Wiel, P., Clevers, H. C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2515 · Cited by 91
An integrative deep learning framework for classifying molecular subtypes of breast cancer
Mohaiminul Islam, M., Huang, S., Ajwad, R., Chi, C., Wang, Y., & Hu, P. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.005 · Cited by 90
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Haider, S. A., McIntyre, A., van Stiphout, R. G. P. M., Winchester, L. M., Wigfield, S., Harris, A. L., & Buffa, F. M. (2016) · Genome biology · doi:10.1186/s13059-016-0999-8 · Cited by 92
Cheung, A., Opzoomer, J. W., Ilieva, K. M., Gazińska, P., Hoffmann, R. M., Mirza, H., Marlow, R., Francesch-Domenech, E., Fittall, M. W., Dominguez-Rodriguez, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0652 · Cited by 90
Self-citationTP53 Mutations Promote Immunogenic Activity in Breast Cancer
Liu, Z., Jiang, Z., Gao, Y., Wang, L., Chen, C., & Wang, X. (2018) · Journal of Oncology · doi:10.1155/2019/5952836 · Cited by 90
Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
Taurin, S., & Alkhalifa, H. (2020) · Neoplasia · doi:10.1016/j.neo.2020.09.009 · Cited by 96
Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
Loizides, S., & Constantinidou, A. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.1095839 · Cited by 90
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
Zeng, P. Y., Prokopec, S. D., Lai, S. Y., Pinto, N. C., Chan‐Seng‐Yue, M., Clifton-Bligh, R. J., Williams, M. D., Howlett, C. J., Plantinga, P., Cecchini, M. J., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113826 · Cited by 95
Molecular Classification of Infiltrating Breast Cancer: Toward Personalized Therapy
Trop, I., LeBlanc, S. M., David, J., Lalonde, L., Tran‐Thanh, D., Labelle, M., & Khoury, M. M. E. (2014) · Radiographics · doi:10.1148/rg.345130049 · Cited by 90
Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
Mesci, A., Huang, X., Taeb, S., Jahangiri, S., Kim, Y., Fokas, E., Bruce, J., Leong, H. S., & Liu, S. K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.105 · Cited by 90
Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., Nagahashi, M., & Takabe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186708 · Cited by 89
Kok, Y. P., Llobet, S. G., Schoonen, P. M., Everts, M., Bhattacharya, A., Fehrmann, R. S. N., van den Tempel, N., & van Vugt, M. A. T. M. (2020) · Oncogenesis · doi:10.1038/s41389-020-00270-2 · Cited by 89
Insulin and IGFs in Obesity-Related Breast Cancer
Belardi, V., Gallagher, E. J., Novosyadlyy, R., & LeRoith, D. (2013) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-013-9303-7 · Cited by 94
The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation
Luo, M., Gong, C., Chen, C.-H., Hu, H., Huang, P., Zheng, M., Yao, Y., Wei, S., Wulf, G. M., Lieberman, J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.002 · Cited by 91
Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease?Preprint
da Costa, D. C. F., de Oliveira, G. A. P., Cino, E. A., Soares, I. N., Rangel, L. P., & Silva, J. L. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023614 · Cited by 89
The AURORA initiative for metastatic breast cancer
Zardavas, D., Maetens, M., Irrthum, A., Goulioti, T., Engelen, K., Fumagalli, D., Salgado, R., Aftimos, P. G., Saini, K. S., Sotiriou, C. P., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.341 · Cited by 88
Liu, C., Srihari, S., Cao, K. L., Chenevix‐Trench, G., Simpson, P. T., Ragan, M. A., & Khanna, K. K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku284 · Cited by 91
Rapid learning for precision oncology
Shrager, J., & Tenenbaum, J. M. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.244 · Cited by 88
Leukaemia 'firsts' in cancer research and treatment
Greaves, M. F. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.3 · Cited by 90
Tang, Q., Moore, J. C., Ignatius, M. S., Tenente, I. M., Hayes, M. N., Garcia, E. G., Yordán, N. T., Bourque, C., He, S., Blackburn, J. S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10358 · Cited by 91
Prognostic value of a newly identified MALAT1 alternatively spliced transcript in breast cancer
Meseure, D., Vacher, S., Lallemand, F., Alsibai, K. D., Hatem, R., Chemlali, W., Nicolas, A., de Koning, L., Pasmant, É., Callens, C., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.123 · Cited by 88
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression
Zheng, Y.-Z., Xue, M., Shen, H.-J., Li, X.-G., Ma, D., Gong, Y., Liu, Y., Qiao, F., Xie, H.-Y., Lian, B., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3514 · Cited by 91
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
Yanovich, G., Agmon, H., Harel, M., Sonnenblick, A., Peretz, T., & Geiger, T. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1079 · Cited by 92
Calcium signalling and breast cancer
So, C. L., Saunus, J. M., Roberts‐Thomson, S. J., & Monteith, G. R. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.11.001 · Cited by 91
Chen, X., Chang, C., Spoerke, J. M., Yoh, K. E., Kapoor, V., Baudo, C. D., Aimi, J., Yu, M., Liang-Chu, M. M. Y., Suttmann, R., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1593 · Cited by 90
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer
Zhao, Z.-M., Yost, S. E., Hutchinson, K. E., Li, S. M., Yuan, Y., Noorbakhsh, J., Liu, Z., Warden, C., Johnson, R. M., Wu, X., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5290-4 · Cited by 88
Self-citationParashar, D., Geethadevi, A., Aure, M. R. R., Mishra, J., George, J., Chen, C., Mishra, M. K., Tahiri, A., Zhao, W., Nair, B. J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.11.085 · Cited by 88
Zheng, S., Zou, Y., Liang, J., Xiao, W., Yang, A., Meng, T., Lu, S., Luo, Z.-B., & Xie, X. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12747 · Cited by 88
Oshi, M., Gandhi, S., Yan, L., Tokumaru, Y., Wu, R., Yamada, A., Matsuyama, R., Endo, I., & Takabe, K. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06633-0 · Cited by 88
Krings, G., Joseph, N. M., Bean, G. R., Solomon, D. A., Onodera, C. S., Talevich, E., Yeh, I., Grenert, J. P., Hosfield, E. M., Crawford, E. D., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.32 · Cited by 88
Guo, X., Lin, W., Bao, J., Cai, Q., Pan, X., Bai, M., Yuan, Y., Shi, J., Sun, Y., Han, M.-R., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.03.016 · Cited by 89
Self-citationMahara, S., Lee, P. L., Feng, M., Tergaonkar, V., Chng, W. J., & Yu, Q. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602079113 · Cited by 87
Dillon, L. M., Bean, J. R., Yang, W., Shee, K., Symonds, L. K., Balko, J. M., McDonald, W. H., Liu, S., Gonzalez-Angulo, A. M., Mills, G. B., et al. (2014) · Oncogene · doi:10.1038/onc.2014.328 · Cited by 87
Algorithmic methods to infer the evolutionary trajectories in cancer progression
Caravagna, G., Graudenzi, A., Ramazzotti, D., Pamplona, R. S., Sano, L. D., Mauri, G., Moreno, V. R., Antoniotti, M., & Mishra, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520213113 · Cited by 89
Liu, L., Zhou, X., Zhang, Y., Pu, J., Yang, L., Yuan, S., Zhao, L., Zhou, C., Zhang, H., & Xie, P. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0018-1 · Cited by 88
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
Adams, C. R., Htwe, H. H., Marsh, T., Wang, A. L., Montoya, M., Subbaraj, L., Tward, A. D., Bardeesy, N. M., & Perera, R. M. (2019) · eLife · doi:10.7554/elife.45313 · Cited by 88
Johansson, A. L. V., Trewin-Nybråten, C. B., Fredriksson, I., Reinertsen, K. V., Russnes, H. G., & Ursin, G. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01393-z · Cited by 91
Oesterreich, S., Nasrazadani, A., Zou, J., Carleton, N. M., Onger, T., Wright, M. D., Li, Y., Demanelis, K., Ramaswamy, B., Tseng, G. C., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac157 · Cited by 90
All models are wrong and yours are useless: making clinical prediction models impactful for patients
Markowetz, F. M. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00553-6 · Cited by 90
Self-citationResearch needs in breast cancer
Cardoso, F., Harbeck, N., Barrios, C. H., Bergh, J. C. S., Cortés, J., Saghir, M. Z., Francis, P. A., Hudis, C. A., Ohno, S., Partridge, A. H., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw571 · Cited by 89
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyPreprint
Barrueco, R. R., Nekritz, E. A., Bertucci, F., Yu, J., Sanchez-Garcia, F., Zeleke, T. Z., Gorbatenko, A., Birnbaum, D., Ezhkova, E., Cordon‐Cardo, C., et al. (2017) · Genes & Development · doi:10.1101/gad.292318.116 · Cited by 87
Knutson, T. P., Truong, T. H., Ma, S., Brady, N. J., Sullivan, M. E., Raj, G. V., Schwertfeger, K. L., & Lange, C. A. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0462-7 · Cited by 86
Boyle, S. T., Poltavets, V., Kular, J., Pyne, N. T., Sandow, J. J., Lewis, A. C., Murphy, K. J., Kolesnikoff, N., Moretti, P. A. B., Tea, M. N., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0523-y · Cited by 86
Breast Cancer Heterogeneity and Response to Novel Therapeutics
Baliu‐Piqué, M., Pandiella, A., & Ocaña, A. (2020) · Cancers · doi:10.3390/cancers12113271 · Cited by 88
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion
Yao, S., Cheng, T. D., Elkhanany, A. M., Yan, L., Omilian, A. R., Abrams, S. I., Evans, S. S., Hong, C., Qi, Q., Davis, W., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa215 · Cited by 86
Jeschke, J., Collignon, É., Wardi, C. A., Krayem, M., Bizet, M., Jia, Y., Garaud, S., Wimana, Z., Calonne, E., Hassabi, B., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00223-7 · Cited by 86
Kawiak, A., & Kostecka, A. (2022) · Cancers · doi:10.3390/cancers14020279 · Cited by 93
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Mehraj, U., Mushtaq, U., Mir, M. A., Saleem, A., Macha, M. A., Lone, M. N., Hamid, A., Zargar, M. A., Ahmad, S. M., & Wani, N. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.008 · Cited by 88
Naume, B., Synnestvedt, M., Falk, R. S., Wiedswang, G., Weyde, K., Risberg, T., Kersten, C., Mjaaland, I., Vindi, L., Sommer, H., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.9327 · Cited by 88
Metadata
- Authors
- METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., Yuan, Y., Gräf, S., Ha, G., Haffari, G., Bashashati, A., Russell, R., McKinney, S., Langerød, A., Green, A., Provenzano, E., Wishart, G., Pinder, S., Watson, P., Markowetz, F., Murphy, L., Ellis, I., Purushotham, A., Børresen-Dale, A.-L., Brenton, J. D., Tavaré, S., Caldas, C., & Aparicio, S.
- Affiliations
- University of Cambridge (GB)
- University of British Columbia (CA)
- Oslo University Hospital (NO)
- University of Nottingham (GB)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- King's College London (GB)
- University of Southern California (US)
- Corresponding author
- Caldas, Carlos
- Aparicio, Samuel
- ORCID
- Curtis, Christina
- Shah, Sohrab P.
- Chin, Suet-Feung
- Turashvili, Gulisa
- Rueda, Oscar M.
- Dunning, Mark J.
- Speed, Doug
- Lynch, Andy G.
- Samarajiwa, Shamith
- Yuan, Yinyin
- Gräf, Stefan
- Ha, Gavin
- Haffari, Gholamreza
- Bashashati, Ali
- Green, Andrew
- Provenzano, Elena
- Wishart, Gordon
- Pinder, Sarah
- Watson, Peter
- Markowetz, Florian
- Murphy, Leigh
- Ellis, Ian
- Purushotham, Arnie
- Brenton, James D.
- Tavaré, Simon
- Caldas, Carlos
- Aparicio, Samuel
- Venue
- Nature
- Published
- 2012-04-18
- Volume
- 486
- Issue
- 7403
- Pages
- 346-352
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3440846
- OpenAlex
- W2005895632
- Cited by
- 6,097
- References
- 32
- Citations by year
- 2026: 341 · 2025: 411 · 2024: 458 · 2023: 497 · 2022: 496 · 2021: 615 · 2020: 533 · 2019: 449 · 2018: 426 · 2017: 361 · 2016: 373 · 2015: 378 · 2014: 339 · 2013: 291 · 2012: 119
- FWCI
- 119.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- University of Southern California
- Michael Smith Health Research BC
- Cancer Research UK (A7199, 15601, 19556)
- National Institute for Health and Care Research (ACF-2012-14-006, NF-SI-0611-10154)
- University of Cambridge
- King's College London
- National Institutes of Health
- BC Cancer Agency
- NIHR Cambridge Biomedical Research Centre
- National Human Genome Research Institute (P50-HG02790, P50HG002790)
- Division of Mathematical Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- breast cancer, copy number alterations, somatic copy number alterations, gene expression, single nucleotide polymorphisms, PPP2R2A, MTAP, MAP2K4, estrogen receptor-positive breast cancer, adaptive immune response, basal-like breast cancer, chromosome 5 deletion, molecular stratification, prognosis
- MeSH terms
- Breast Neoplasms, Female, Humans, Prognosis, Genome, Human, Gene Expression Regulation, Neoplastic, Treatment Outcome, Polymorphism, Single Nucleotide, Gene Expression Profiling, Genomics, MAP Kinase Kinase 4, Genes, Neoplasm, Kaplan-Meier Estimate, Gene Regulatory Networks, Protein Phosphatase 2, DNA Copy Number Variations
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
